2008-08-06T11:34:00
The Royal Pharmaceutical Society of Great Britain has welcomed a move by the Medicines and Healthcare Products Regulatory Agency to reclassify azithromycin - an antibiotic used to treat chlamydia - as an over-the-counter drug.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud